Regenerative Therapy for Cartilage Damage

The subject technology discloses a tissue engineering method for treating cartilage damage. Stem cells from bone marrow are attached to a novel scaffold, hyaluronic acid-coated fibrin microbeads, and transferred to a live host to form cartilage. The regenerated cartilage is stable and not hypertrophic, which has been problematic in the current regenerative methods.IC: NIDCRNIH Ref. No.: E-152-2017/0Advantages: Coating with hyaluronic acid makes the fibrin microbeads more stable for mature cartilage formation.The new hyaline cartilage is stable and hypertrophy-resistant.Applications: A novel scaffold, hyaluronic acid-coated fibrin microbeads.Cartilage repair.Provider Technology ID: 3242Updated On: Jan 25, 2018Date Published: Thursday, January 25, 2018Provider Classifications: Patent Application: 62/513,874Publications: Patent Authority: USLicensing Contacts: Lead Inventor: Inventor IC: NIDCRSynerra MedicalHadassah Medical CenterNIDCRHadassah Medical CenterInventor Lab URL: http://irp.nih.gov/pi/pamela-robeyLPM FIrst Name: YunLPM Last Name: MeiLPM Address: 6701 Democracy Blvd, 1 Democracy Plaza, Rm 687LPM City: BethesdaInv Is lead: LPM Zip: 20817-4878LPM State: MDLPM Phone: [phone]LPM Email: [e-mail] Suffix: M.D.LPM Organization: NIH Office of Technology TransferLPM Fax: [phone]DTDT Classification: ArthritisTherapeutic (...

Source: NIH OTT Licensing Opportunities - January 25, 2018 Category: Research Authors: ajoyprabhu3 Source Type: research